Similar articles

• Chronic allograft nephropathy.

  Pietrzyk M, Hoffmann U, Krämer BK. Pietrzyk M, et al. N Engl J Med. 2004 Mar 18;350(12):1254-6; author reply 1254-6. N Engl J Med. 2004. PMID: 15031859 No abstract available.
• Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.

  Gaston RS. Gaston RS. Clin J Am Soc Nephrol. 2009 Dec;4(12):2029-34. doi: 10.2215/CJN.03820609. Epub 2009 Oct 22. Clin J Am Soc Nephrol. 2009. PMID: 19850771 Review.
• Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.

  Kandaswamy R, Humar A, Casingal V, Gillingham KJ, Ibrahim H, Matas AJ. Kandaswamy R, et al. Transplantation. 2007 Mar 27;83(6):722-6. doi: 10.1097/01.tp.0000256179.14038.e2. Transplantation. 2007. PMID: 17414704
• What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?

  Hanto DW, Chudzinski R. Hanto DW, et al. Transplantation. 2009 Jan 27;87(2):164-5. doi: 10.1097/TP.0b013e318192790f. Transplantation. 2009. PMID: 19155968 No abstract available.
• Chronic cyclosporine nephropathy in renal transplantation.

  Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Bennett WM, et al. Transplant Proc. 1996 Aug;28(4):2100-3. Transplant Proc. 1996. PMID: 8769166 Review. No abstract available.